AXOVANT GENE THERAPIES LTD - COM (AXGT)

CUSIP: G0750W203

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -11,414,562
Total reported value: $0
Number of holders: 0
Value change: -$52,736,626
Number of sells: 38

Quarterly Holders Quick Answers

What is CUSIP G0750W203?
CUSIP G0750W203 identifies AXGT - AXOVANT GENE THERAPIES LTD - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2020

Recent filing periods for CUSIP G0750W203:

Q4 2020 Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019

There are no holders of AXGT - AXOVANT GENE THERAPIES LTD - COM as of Q4 2020.